BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morera-Fumero AL, Díaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, Cejas-Mendez MDR. Day/night changes in serum S100B protein concentrations in acute paranoid schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2017;75:207-12. [PMID: 28188811 DOI: 10.1016/j.pnpbp.2017.02.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Zakowicz P, Skibińska M, Waśniewski F, Skulimowski B, Pawlak J. Plasma Biomarkers in Early-Onset Schizophrenia. Case-Control Study in Adolescent Population.. [DOI: 10.21203/rs.3.rs-2097374/v1] [Reference Citation Analysis]
2 Ma H, Cheng N, Zhang C. Schizophrenia and Alarmins. Medicina (Kaunas) 2022;58:694. [PMID: 35743957 DOI: 10.3390/medicina58060694] [Reference Citation Analysis]
3 Eraslan AN, Durukan İ, Bodur Ş, Demircan Ö. Evaluation of Serum S100B Levels in Male Children Younger than 6 Years Old with Autism Spectrum Disorder: A Psychiatric and Biochemical Perspective. Düzce Tıp Fakültesi Dergisi 2021. [DOI: 10.18678/dtfd.976021] [Reference Citation Analysis]
4 Zhang P, Li YX, Zhang ZZ, Yang Y, Rao JX, Xia L, Li XY, Chen GH, Wang F. Astroglial Mechanisms Underlying Chronic Insomnia Disorder: A Clinical Study. Nat Sci Sleep 2020;12:693-704. [PMID: 33117005 DOI: 10.2147/NSS.S263528] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Arrais AC, Melo LHMF, Norrara B, Almeida MAB, Freire KF, Melo AMMF, Oliveira LCD, Lima FOV, Engelberth RCGJ, Cavalcante JDS, Araújo DPD, Guzen FP, Freire MAM, Cavalcanti JRLP. S100B protein: general characteristics and pathophysiological implications in the Central Nervous System. International Journal of Neuroscience. [DOI: 10.1080/00207454.2020.1807979] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Futtrup J, Margolinsky R, Benros ME, Moos T, Routhe LJ, Rungby J, Krogh J. Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies. Brain Behav Immun Health 2020;6:100102. [PMID: 34589864 DOI: 10.1016/j.bbih.2020.100102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
7 Díaz-mesa E, Morera-fumero A, Abreu-gonzalez P, Pavesi AS, Povedano-garcía L, Yelmo-cruz S, Cejas-mendez M, Fernandez-lopez L, Henry-benítez M. P.675 Relationship between S100B protein and therapeutic adherence in a sample of acute and stabilized schizophrenic patients. European Neuropsychopharmacology 2019;29:S457. [DOI: 10.1016/j.euroneuro.2019.09.646] [Reference Citation Analysis]
8 Gannon JM, Kelly DL, Besch A, Thakur T, Khurana N, Shurin MR, Shurin GV, Brar JS, Cihakova D, Talor MV, Chengappa KNR. Racial Differences in S100b Levels in Persons with Schizophrenia. Psychiatr Q 2020;91:137-45. [DOI: 10.1007/s11126-019-09687-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Wu YF, Sytwu HK, Lung FW. Human Aquaporin 4 Gene Polymorphisms and Haplotypes Are Associated With Serum S100B Level and Negative Symptoms of Schizophrenia in a Southern Chinese Han Population. Front Psychiatry 2018;9:657. [PMID: 30618856 DOI: 10.3389/fpsyt.2018.00657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Deng H, Kahlon RS, Mohite S, Amin PA, Zunta-Soares G, Colpo GD, Stertz L, Fries GR, Walss-Bass C, Soares JC, Okusaga OO. Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia. Psychiatr Q 2018;89:53-60. [PMID: 28435992 DOI: 10.1007/s11126-017-9514-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]